
0.0211 Delayed Data As of Jun 01 | ![]() Today’s Change | 0.01 Today|||52-Week Range 1.57 | -87.94% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +14,118.01% increase from the last price of 0.02.
The current consensus among 1 polled investment analysts is to Hold stock in Rubius Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.